Objective: Recovery from acute Bell's palsy (BP) is variable and there are few predictors of response. We evaluated the usefulness of motor unit number index (MUNIX) to predict outcome in BP.
Methods: This prospective study evaluated the prognostic utility of MUNIX in 64 consecutive patients with acute unilateral BP. Within 7 days of symptom onset, participants underwent bilateral MUNIX testing of three facial muscles: orbicularis oculi muscle, zygomatic muscle, and orbicularis oris muscle. Clinical outcomes were assessed using the House-Brackmann Grading System (HBGS) by two blinded neurologists at baseline, 1 month, and 3 months. All patients received prednisolone treatment and regular rehabilitation.
Results: At 1-month follow-up, 26 patients (65%) achieved good recovery (HBGS I-II). The zygomatic muscle demonstrated superior prognostic performance, with absolute value of affected-to-unaffected side MUNIX difference in the zygomatic muscle (ΔMUNIX zygomatic muscle) >14 predicting poor recovery (AUC =0.804, 95% CI 0.667-0.940; p =0.002), showing 85% sensitivity and 79% specificity. Three-month outcomes (n=20) confirmed ΔMUNIX zygomatic muscle >16 as the optimal cutoff (AUC =0.893, 95% CI 0.748-1.000; p =0.006).
Conclusion: These findings establish MUNIX, particularly zygomatic muscle measurements, as an objective, non-invasive prognostic tool for early BP management.
目的:急性贝尔氏麻痹(BP)的恢复是可变的,其反应的预测因素很少。我们评估了运动单元数指数(MUNIX)预测BP预后的有效性。方法:本前瞻性研究评估了64例连续急性单侧BP患者的预后。在症状出现的7天内,参与者进行了双侧三个面部肌肉的MUNIX测试:眼轮匝肌、颧肌和口轮匝肌。临床结果由两名盲法神经科医生在基线、1个月和3个月时使用House-Brackmann评分系统(HBGS)进行评估。所有患者均接受强的松龙治疗和常规康复治疗。结果:随访1个月,26例(65%)患者恢复良好(HBGS I-II)。颧肌表现出良好的预后表现,颧肌(ΔMUNIX颧肌)受损伤侧与未受损伤侧的mmx差绝对值>14预测恢复不良(AUC =0.804, 95% CI 0.667-0.940; p =0.002),敏感性85%,特异性79%。三个月的结果(n=20)证实ΔMUNIX颧肌bbb16为最佳临界值(AUC =0.893, 95% CI 0.748-1.000; p =0.006)。结论:这些发现确立了MUNIX,特别是颧肌测量,作为早期BP治疗的客观、非侵入性预后工具。
{"title":"Motor Unit Number Index (MUNIX) as an Early Prognostic Biomarker in Acute Bell's Palsy: A Prospective Cohort Study.","authors":"Xiaoxiao Zheng, Xiuli Li, Guangju Qi, Hongjing Liu, Jing Chen, Xinhong Feng","doi":"10.2147/IJGM.S558041","DOIUrl":"https://doi.org/10.2147/IJGM.S558041","url":null,"abstract":"<p><strong>Objective: </strong>Recovery from acute Bell's palsy (BP) is variable and there are few predictors of response. We evaluated the usefulness of motor unit number index (MUNIX) to predict outcome in BP.</p><p><strong>Methods: </strong>This prospective study evaluated the prognostic utility of MUNIX in 64 consecutive patients with acute unilateral BP. Within 7 days of symptom onset, participants underwent bilateral MUNIX testing of three facial muscles: orbicularis oculi muscle, zygomatic muscle, and orbicularis oris muscle. Clinical outcomes were assessed using the House-Brackmann Grading System (HBGS) by two blinded neurologists at baseline, 1 month, and 3 months. All patients received prednisolone treatment and regular rehabilitation.</p><p><strong>Results: </strong>At 1-month follow-up, 26 patients (65%) achieved good recovery (HBGS I-II). The zygomatic muscle demonstrated superior prognostic performance, with absolute value of affected-to-unaffected side MUNIX difference in the zygomatic muscle (ΔMUNIX zygomatic muscle) >14 predicting poor recovery (AUC =0.804, 95% CI 0.667-0.940; <i>p</i> =0.002), showing 85% sensitivity and 79% specificity. Three-month outcomes (n=20) confirmed ΔMUNIX zygomatic muscle >16 as the optimal cutoff (AUC =0.893, 95% CI 0.748-1.000; <i>p</i> =0.006).</p><p><strong>Conclusion: </strong>These findings establish MUNIX, particularly zygomatic muscle measurements, as an objective, non-invasive prognostic tool for early BP management.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"558041"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cardiovascular-kidney-metabolic (CKM) syndrome stage 3 is a high-risk condition for cardiovascular disease (CVD), characterized by intertwined metabolic dysregulation, chronic inflammation, and immune dysfunction. This study aimed to evaluate the association and predictive value of the C-reactive protein-lymphocyte-albumin (CALLY) index for CVD in this population.
Methods: In a retrospective cohort of patients with CKM stage 3, the CALLY index was calculated from baseline laboratory data. Its association with incident CVD was assessed using multivariable Cox proportional hazards models. To test robustness, sensitivity and subgroup analyses were performed. Predictive performance was evaluated by time-dependent receiver operating characteristic (ROC) analysis, integrated discrimination improvement (IDI), and net reclassification improvement (NRI).
Results: Among 826 patients followed for a median of 51 months, a higher CALLY index was independently associated with a lower risk of CVD (adjusted hazard ratio 0.37, 95% CI: 0.25-0.55). The association remained robust in sensitivity and subgroup analyses. The index demonstrated superior discrimination for CVD (area under the curve 0.806, 95% CI: 0.774-0.838). The CALLY index provided significant incremental predictive value compared to using its individual components (CRP, albumin, or lymphocyte count alone).
Conclusion: A lower CALLY index is independently associated with an increased risk of CVD in patients with CKM stage 3 and exhibits robust predictive performance. This readily available composite biomarker may aid in cardiovascular risk stratification for this high-risk group.
{"title":"Association and Predictive Value of C-Reactive Protein-Lymphocyte-Albumin (CALLY) Index with Cardiovascular Disease in Patients with Cardiovascular-Kidney-Metabolic Syndrome Stage 3.","authors":"Mei Yuan, Luohua Li, Yueyuan Hou, Ling Wei, Rou Zhang, Hongying Jiang","doi":"10.2147/IJGM.S576278","DOIUrl":"https://doi.org/10.2147/IJGM.S576278","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular-kidney-metabolic (CKM) syndrome stage 3 is a high-risk condition for cardiovascular disease (CVD), characterized by intertwined metabolic dysregulation, chronic inflammation, and immune dysfunction. This study aimed to evaluate the association and predictive value of the C-reactive protein-lymphocyte-albumin (CALLY) index for CVD in this population.</p><p><strong>Methods: </strong>In a retrospective cohort of patients with CKM stage 3, the CALLY index was calculated from baseline laboratory data. Its association with incident CVD was assessed using multivariable Cox proportional hazards models. To test robustness, sensitivity and subgroup analyses were performed. Predictive performance was evaluated by time-dependent receiver operating characteristic (ROC) analysis, integrated discrimination improvement (IDI), and net reclassification improvement (NRI).</p><p><strong>Results: </strong>Among 826 patients followed for a median of 51 months, a higher CALLY index was independently associated with a lower risk of CVD (adjusted hazard ratio 0.37, 95% CI: 0.25-0.55). The association remained robust in sensitivity and subgroup analyses. The index demonstrated superior discrimination for CVD (area under the curve 0.806, 95% CI: 0.774-0.838). The CALLY index provided significant incremental predictive value compared to using its individual components (CRP, albumin, or lymphocyte count alone).</p><p><strong>Conclusion: </strong>A lower CALLY index is independently associated with an increased risk of CVD in patients with CKM stage 3 and exhibits robust predictive performance. This readily available composite biomarker may aid in cardiovascular risk stratification for this high-risk group.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"576278"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13007696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S579135
Ke He, Jinbo Zhao, Changjiang Zhang
Background: Atrial fibrillation (AF) is a common arrhythmia among patients with coronary heart disease (CHD), and inflammatory response plays a key role in its pathogenesis. The pan-immune-inflammation value (PIV), a novel composite marker reflecting systemic inflammation, has not been fully investigated for its predictive value in AF among CHD patients.
Methods: This multicenter retrospective study enrolled patients diagnosed with CHD by coronary angiography from two tertiary hospitals. Participants were categorized into AF and non-AF groups. Clinical characteristics and laboratory data were collected. Feature selection was performed using multivariate logistic regression, and significant predictors were incorporated into two models: extreme gradient boosting (XGBoost) and multilayer perceptron (MLP). Model performance was evaluated by area under the ROC curve (AUC) and calibration analysis. Model interpretability was assessed using SHAP (SHapley Additive exPlanations) values, and partial dependence plots (PDPs) were applied to explore variable interactions.
Results: Compared with the non-AF group, the AF group had significantly higher levels of PIV, age, AST, WBC, and TBIL. Logistic regression identified PIV, age, and diabetes as independent predictors of AF, while sex, left main coronary artery disease (LM), and AST showed borderline significance. The XGBoost model achieved superior performance (AUC = 0.79 in training and 0.73 in testing) compared to the MLP model (AUC = 0.75 and 0.69, respectively), with better calibration consistency. SHAP analysis indicated that PIV was the most influential feature, with higher values associated with increased AF risk. PDPs further demonstrated synergistic effects between PIV and other key variables.
Conclusion: PIV is a valuable predictor of AF in CHD patients. The XGBoost model outperformed the deep learning model in this context and may serve as a robust tool for individualized AF risk assessment.
{"title":"The Predictive Value of the Pan-Immune-Inflammation Value for Atrial Fibrillation Risk in Patients with Coronary Artery Disease: A Multicenter Machine Learning Study.","authors":"Ke He, Jinbo Zhao, Changjiang Zhang","doi":"10.2147/IJGM.S579135","DOIUrl":"https://doi.org/10.2147/IJGM.S579135","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is a common arrhythmia among patients with coronary heart disease (CHD), and inflammatory response plays a key role in its pathogenesis. The pan-immune-inflammation value (PIV), a novel composite marker reflecting systemic inflammation, has not been fully investigated for its predictive value in AF among CHD patients.</p><p><strong>Methods: </strong>This multicenter retrospective study enrolled patients diagnosed with CHD by coronary angiography from two tertiary hospitals. Participants were categorized into AF and non-AF groups. Clinical characteristics and laboratory data were collected. Feature selection was performed using multivariate logistic regression, and significant predictors were incorporated into two models: extreme gradient boosting (XGBoost) and multilayer perceptron (MLP). Model performance was evaluated by area under the ROC curve (AUC) and calibration analysis. Model interpretability was assessed using SHAP (SHapley Additive exPlanations) values, and partial dependence plots (PDPs) were applied to explore variable interactions.</p><p><strong>Results: </strong>Compared with the non-AF group, the AF group had significantly higher levels of PIV, age, AST, WBC, and TBIL. Logistic regression identified PIV, age, and diabetes as independent predictors of AF, while sex, left main coronary artery disease (LM), and AST showed borderline significance. The XGBoost model achieved superior performance (AUC = 0.79 in training and 0.73 in testing) compared to the MLP model (AUC = 0.75 and 0.69, respectively), with better calibration consistency. SHAP analysis indicated that PIV was the most influential feature, with higher values associated with increased AF risk. PDPs further demonstrated synergistic effects between PIV and other key variables.</p><p><strong>Conclusion: </strong>PIV is a valuable predictor of AF in CHD patients. The XGBoost model outperformed the deep learning model in this context and may serve as a robust tool for individualized AF risk assessment.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"579135"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13012144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S552633
Yufeng Yang, Fang Wang, Zeyuan Li, Zhu Wang
Objective: This study aimed to develop and validate a prognostic nomogram integrating clinical and laboratory variables to predict prolonged hospital stay in patients undergoing surgery for gastrointestinal (GI) perforation, facilitating early risk stratification and informed clinical decision-making.
Patients and methods: A retrospective retrospective single-center study included 164 surgical patients with GI perforation from 2022-2024. Variables encompassed demographics, perforation characteristics, and preoperative/postoperative laboratory markers. The least absolute shrinkage and selection operator (LASSO) regression identified key predictors, followed by multivariate logistic regression to construct a nomogram. Model performance was evaluated using the receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).
Results: Upper GI perforation (OR=2.93, 95% CI:1.23-6.98), smaller perforation diameter (OR=0.48, 95% CI:0.28-0.82), and lower preoperative albumin (OR=1.10 per unit increase, 95% CI:1.03-1.17) independently predicted prolonged hospitalization. The nomogram demonstrated good discrimination (training AUC=0.75; validation AUC=0.79) and calibration. DCA confirmed clinical utility, with net benefit surpassing "treat all" or "treat none" strategies across risk thresholds.
Conclusion: In summary, we developed and validated a nomogram that effectively identifies patients at high risk for prolonged hospitalization after GI perforation surgery by integrating three routinely available clinical parameters. This tool aids in optimizing resource allocation and personalized perioperative management. Further multicenter validation is warranted to enhance generalizability and incorporate dynamic biomarkers.
{"title":"Development of a Prognostic Model for Prolonged Hospital Stay After Gastrointestinal Perforation Surgery.","authors":"Yufeng Yang, Fang Wang, Zeyuan Li, Zhu Wang","doi":"10.2147/IJGM.S552633","DOIUrl":"https://doi.org/10.2147/IJGM.S552633","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to develop and validate a prognostic nomogram integrating clinical and laboratory variables to predict prolonged hospital stay in patients undergoing surgery for gastrointestinal (GI) perforation, facilitating early risk stratification and informed clinical decision-making.</p><p><strong>Patients and methods: </strong>A retrospective retrospective single-center study included 164 surgical patients with GI perforation from 2022-2024. Variables encompassed demographics, perforation characteristics, and preoperative/postoperative laboratory markers. The least absolute shrinkage and selection operator (LASSO) regression identified key predictors, followed by multivariate logistic regression to construct a nomogram. Model performance was evaluated using the receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).</p><p><strong>Results: </strong>Upper GI perforation (OR=2.93, 95% CI:1.23-6.98), smaller perforation diameter (OR=0.48, 95% CI:0.28-0.82), and lower preoperative albumin (OR=1.10 per unit increase, 95% CI:1.03-1.17) independently predicted prolonged hospitalization. The nomogram demonstrated good discrimination (training AUC=0.75; validation AUC=0.79) and calibration. DCA confirmed clinical utility, with net benefit surpassing \"treat all\" or \"treat none\" strategies across risk thresholds.</p><p><strong>Conclusion: </strong>In summary, we developed and validated a nomogram that effectively identifies patients at high risk for prolonged hospitalization after GI perforation surgery by integrating three routinely available clinical parameters. This tool aids in optimizing resource allocation and personalized perioperative management. Further multicenter validation is warranted to enhance generalizability and incorporate dynamic biomarkers.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"552633"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S580403
Jun Jin, Xingliang Zhang, Zhe Zhao, Jie Li, Tingjun Hu, Meixia Yuan, Yingying Ke, Beiyun Wang
Purpose: Venous thromboembolism (VTE) poses a significant health risk for the elderly. This study aims to evaluate the knowledge, attitudes, and practices (KAP) concerning VTE among elderly individuals.
Patients and methods: This cross-sectional study was conducted between September and October 2024 among elderly inpatients and outpatients at the Department of Gerontology, Shanghai Sixth People's Hospital in China, involving 540 participants. Demographic characteristics and KAP scores were collected using a self-designed questionnaire. Confirmatory factor analysis demonstrated acceptable construct validity, and a cutoff of 70% of the maximum score was applied to define adequate knowledge, positive attitudes, and proactive practices. Univariate and multivariate regression analyses were used to identify factors associated with KAP scores, and structural equation modeling (SEM) was performed to examine the direct and indirect relationships among knowledge, attitudes, and practices.
Results: Among respondents, 272 (50.4%) were male, and 67 (12.4%) reported a history of VTE. Mean scores were 8.04 ± 5.22 (knowledge), 40.99 ± 4.10 (attitude), and 28.77 ± 5.12 (practice), indicating inadequate knowledge, generally positive attitudes, and moderately proactive practices. SEM revealed that knowledge significantly influenced both attitude (β = 0.365, P < 0.001) and practice (β = 0.306, P < 0.001), while attitude also affected practice (β = 0.219, P < 0.001). Knowledge further had an indirect effect on practice via attitude (β = 0.080, P < 0.001).
Conclusion: These findings highlight critical knowledge gaps among elderly individuals, particularly in mechanical prophylaxis and symptom recognition, underscoring the urgent need for targeted educational interventions to improve VTE prevention strategies.
目的:静脉血栓栓塞(VTE)对老年人的健康构成重大风险。本研究旨在评估老年人关于静脉血栓栓塞的知识、态度和行为。患者和方法:本横断面研究于2024年9月至10月在中国上海第六人民医院老年科的老年住院和门诊患者中进行,涉及540名参与者。使用自行设计的问卷收集人口统计学特征和KAP得分。验证性因子分析证明了可接受的结构效度,并以最高分数的70%为截止值来定义足够的知识、积极的态度和积极的实践。采用单变量和多变量回归分析来确定与KAP得分相关的因素,并采用结构方程模型(SEM)来检验知识、态度和实践之间的直接和间接关系。结果:272例(50.4%)为男性,67例(12.4%)有静脉血栓栓塞病史。平均得分为知识(8.04±5.22)分、态度(40.99±4.10)分、实践(28.77±5.12)分,表现为知识不足、态度总体积极、行动较为主动。扫描电镜显示,知识显著影响态度(β = 0.365, P < 0.001)和实践(β = 0.306, P < 0.001),态度也显著影响实践(β = 0.219, P < 0.001)。知识进一步通过态度间接影响实践(β = 0.080, P < 0.001)。结论:这些发现突出了老年人的关键知识差距,特别是在机械预防和症状识别方面,强调了迫切需要有针对性的教育干预来改善静脉血栓栓塞预防策略。
{"title":"Knowledge, Attitudes, and Practices Regarding Venous Thromboembolism Among Elderly Chinese Patients: A Cross-Sectional Study.","authors":"Jun Jin, Xingliang Zhang, Zhe Zhao, Jie Li, Tingjun Hu, Meixia Yuan, Yingying Ke, Beiyun Wang","doi":"10.2147/IJGM.S580403","DOIUrl":"https://doi.org/10.2147/IJGM.S580403","url":null,"abstract":"<p><strong>Purpose: </strong>Venous thromboembolism (VTE) poses a significant health risk for the elderly. This study aims to evaluate the knowledge, attitudes, and practices (KAP) concerning VTE among elderly individuals.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted between September and October 2024 among elderly inpatients and outpatients at the Department of Gerontology, Shanghai Sixth People's Hospital in China, involving 540 participants. Demographic characteristics and KAP scores were collected using a self-designed questionnaire. Confirmatory factor analysis demonstrated acceptable construct validity, and a cutoff of 70% of the maximum score was applied to define adequate knowledge, positive attitudes, and proactive practices. Univariate and multivariate regression analyses were used to identify factors associated with KAP scores, and structural equation modeling (SEM) was performed to examine the direct and indirect relationships among knowledge, attitudes, and practices.</p><p><strong>Results: </strong>Among respondents, 272 (50.4%) were male, and 67 (12.4%) reported a history of VTE. Mean scores were 8.04 ± 5.22 (knowledge), 40.99 ± 4.10 (attitude), and 28.77 ± 5.12 (practice), indicating inadequate knowledge, generally positive attitudes, and moderately proactive practices. SEM revealed that knowledge significantly influenced both attitude (β = 0.365, P < 0.001) and practice (β = 0.306, P < 0.001), while attitude also affected practice (β = 0.219, P < 0.001). Knowledge further had an indirect effect on practice via attitude (β = 0.080, P < 0.001).</p><p><strong>Conclusion: </strong>These findings highlight critical knowledge gaps among elderly individuals, particularly in mechanical prophylaxis and symptom recognition, underscoring the urgent need for targeted educational interventions to improve VTE prevention strategies.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"580403"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13012145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To investigate the prognostic value of cell cyclin A2 (CCNA2) in lung adenocarcinoma (LUAD) and to explore its mechanisms in promoting cancer progression.
Patients and methods: In this study, we employed an integrated strategy combining bioinformatics, clinical analysis and molecular biology to elucidate the role of CCNA2 in LUAD. First, comprehensive bioinformatics analyses were performed using public datasets. This included detecting the differential expression of CCNA2 in LUAD versus normal tissues, analyzing its correlation with patient survival and clinical characteristics, and employing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) analysis to predict the functions of CCNA2-associated genes. The relationship between CCNA2 expression and immune infiltration was further examined via the tumor immune estimation resource (TIMER) platform. The expression level of CCNA2 was also confirmed through reverse transcription-quantitative PCR and Western blotting. Additionally, the biological function of CCNA2 was evaluated by constructing an in vitro transfection model.
Results: The results of the present study indicated that CCNA2 was upregulated in LUAD tissues. Cox regression analysis revealed that CCNA2 upregulation is a independent prognostic biomarker for LUAD. Additionally, CCNA2 was markedly associated with immune cell infiltration and immune checkpoint molecules. The results of in vitro experiments confirmed that knockdown of CCNA2 significantly inhibited the proliferation, invasion and migration of H1975 and H1299 cells. Furthermore, CCNA2 was found to promote the invasion and migration of lung cancer cells through the PI3K/AKT signaling pathway.
Conclusion: The present research identified the prognostic signature and biological function of CCNA2 in LUAD, which suggested that CCNA2 may be a potential prognostic biomarker and a pivotal oncogenic driver for this disease.
{"title":"Integrating Bioinformatics and Experimental Validation Identify CCNA2 as a Novel Prognostic Biomarker and Tumor Promoter via the PI3K/AKT Pathway in Lung Adenocarcinoma.","authors":"Jian-Ping Li, Meng-Yu Zhang, Rui Li, Chen Huo, Jia-Jia Qu, Yi-Qing Qu","doi":"10.2147/IJGM.S571529","DOIUrl":"https://doi.org/10.2147/IJGM.S571529","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the prognostic value of cell cyclin A2 (CCNA2) in lung adenocarcinoma (LUAD) and to explore its mechanisms in promoting cancer progression.</p><p><strong>Patients and methods: </strong>In this study, we employed an integrated strategy combining bioinformatics, clinical analysis and molecular biology to elucidate the role of CCNA2 in LUAD. First, comprehensive bioinformatics analyses were performed using public datasets. This included detecting the differential expression of CCNA2 in LUAD versus normal tissues, analyzing its correlation with patient survival and clinical characteristics, and employing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) analysis to predict the functions of CCNA2-associated genes. The relationship between CCNA2 expression and immune infiltration was further examined via the tumor immune estimation resource (TIMER) platform. The expression level of CCNA2 was also confirmed through reverse transcription-quantitative PCR and Western blotting. Additionally, the biological function of CCNA2 was evaluated by constructing an in vitro transfection model.</p><p><strong>Results: </strong>The results of the present study indicated that CCNA2 was upregulated in LUAD tissues. Cox regression analysis revealed that CCNA2 upregulation is a independent prognostic biomarker for LUAD. Additionally, CCNA2 was markedly associated with immune cell infiltration and immune checkpoint molecules. The results of in vitro experiments confirmed that knockdown of CCNA2 significantly inhibited the proliferation, invasion and migration of H1975 and H1299 cells. Furthermore, CCNA2 was found to promote the invasion and migration of lung cancer cells through the PI3K/AKT signaling pathway.</p><p><strong>Conclusion: </strong>The present research identified the prognostic signature and biological function of CCNA2 in LUAD, which suggested that CCNA2 may be a potential prognostic biomarker and a pivotal oncogenic driver for this disease.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"571529"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S549743
Lei Liu, Yi Liu, Min Wu
Background: The therapeutic effects of compound herbs (Radix Paeoniae Rubra, Radix Cirsii Japonici, Gentianae Radix Et Rhizoma, and Cardeniae Fructus) on stomach adenocarcinoma (STAD) remain unclear.
Methods: Active ingredients and their targets from the herbal combination were obtained using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. STAD-related targets were collected from the GeneCards database, and the TCGA-STAD dataset was downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed genes (DEGs) between STAD and normal tissues were screened. The intersection of DEGs, drug targets, and STAD-related targets was taken to determine key targets. A protein-protein interaction (PPI) network was built and hub genes were identified. Functional enrichment analysis and molecular docking of the hub genes were performed. The Cell Counting Kit-8 (CCK8) assay was used to evaluate the effects of the active ingredients on the proliferation of Stomach Gastric Carcinoma cell line 7901 (SGC-7901) and MaKuNo cell line 45 (MKN-45) cells. The Transwell assay was used to evaluate the effect of quercetin on the migration ability of SGC-7901 and MKN-45 cells.
Results: A total of 67 key targets were obtained, among which five hub genes-ESR1 (Estrogen receptor 1), FOS (FBJ murine osteosarcoma viral oncogene homolog), HSP90AA199 (Heat shock protein 90 alpha family class A member 1), JUN (Avian sarcoma virus 17 oncogene homolog), and MMP9 (Matrix Metallopeptidase 9)-were identified. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that these hub genes were significantly associated with the T Helper 17 (Th17) Cell differentiation pathway. Molecular docking predictions suggested that active ingredients such as quercetin could bind effectively to the hub genes, with quercetin showing the strongest binding affinity to FOS. Cell experiments further confirmed that quercetin exhibited the most potent inhibitory effect on the proliferation of STAD cells, with a half-maximal inhibitory concentration (IC50) value of 4 μM. Furthermore, quercetin can significantly inhibit the migration of SGC-7901 and MKN-45 cells.
Conclusion: This study identified five key targets and active compounds in herbal compounds for STAD treatment. These results suggest that quercetin may inhibit STAD progression by targeting FOS, and may have therapeutic potential.
{"title":"Identification of Bioactive Compounds and Molecular Targets of Compound Herbs Against Stomach Adenocarcinoma: A Network Pharmacology Approach.","authors":"Lei Liu, Yi Liu, Min Wu","doi":"10.2147/IJGM.S549743","DOIUrl":"https://doi.org/10.2147/IJGM.S549743","url":null,"abstract":"<p><strong>Background: </strong>The therapeutic effects of compound herbs (Radix Paeoniae Rubra, Radix Cirsii Japonici, Gentianae Radix Et Rhizoma, and Cardeniae Fructus) on stomach adenocarcinoma (STAD) remain unclear.</p><p><strong>Methods: </strong>Active ingredients and their targets from the herbal combination were obtained using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. STAD-related targets were collected from the GeneCards database, and the TCGA-STAD dataset was downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed genes (DEGs) between STAD and normal tissues were screened. The intersection of DEGs, drug targets, and STAD-related targets was taken to determine key targets. A protein-protein interaction (PPI) network was built and hub genes were identified. Functional enrichment analysis and molecular docking of the hub genes were performed. The Cell Counting Kit-8 (CCK8) assay was used to evaluate the effects of the active ingredients on the proliferation of Stomach Gastric Carcinoma cell line 7901 (SGC-7901) and MaKuNo cell line 45 (MKN-45) cells. The Transwell assay was used to evaluate the effect of quercetin on the migration ability of SGC-7901 and MKN-45 cells.</p><p><strong>Results: </strong>A total of 67 key targets were obtained, among which five hub genes-ESR1 (Estrogen receptor 1), FOS (FBJ murine osteosarcoma viral oncogene homolog), HSP90AA199 (Heat shock protein 90 alpha family class A member 1), JUN (Avian sarcoma virus 17 oncogene homolog), and MMP9 (Matrix Metallopeptidase 9)-were identified. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that these hub genes were significantly associated with the T Helper 17 (Th17) Cell differentiation pathway. Molecular docking predictions suggested that active ingredients such as quercetin could bind effectively to the hub genes, with quercetin showing the strongest binding affinity to FOS. Cell experiments further confirmed that quercetin exhibited the most potent inhibitory effect on the proliferation of STAD cells, with a half-maximal inhibitory concentration (IC50) value of 4 μM. Furthermore, quercetin can significantly inhibit the migration of SGC-7901 and MKN-45 cells.</p><p><strong>Conclusion: </strong>This study identified five key targets and active compounds in herbal compounds for STAD treatment. These results suggest that quercetin may inhibit STAD progression by targeting FOS, and may have therapeutic potential.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"549743"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Timely reperfusion is critical for improving outcomes in patients with acute myocardial infarction (AMI), as every delay raises the incidence of complications and mortality. Therefore, we aimed to develop a machine-learning model that quantifies the risk of pre-hospital decision-making delay and visualizes how individual determinants modulate this risk.
Patients and methods: This retrospective study included 594 AMI patients admitted to hospitals in Hainan from January to August 2023. Data were collected via medical systems and surveys. We used the Elastic Net and Boruta algorithms for feature selection and hyperparameter optimization with grid search and 10-fold cross-validation. Six machine learning models were developed: logistic regression, random forest, support vector machine, XGBoost, decision tree, and naive Bayes. The primary metric was the Area Under the Curve (AUC), and SHapley Additive exPlanations (SHAP) were used to assess feature importance.
Results: The medical decision-making delay rate was 61.78%, with a median decision time of 3.98 hours. All models showed good predictive performance, with the random forest model excelling, achieving an AUC of 0.91, accuracy of 0.92, recall of 0.98, F1 score of 0.93, and specificity of 0.81. SHAP analysis revealed that pain severity, disease type, and history of myocardial infarction were the most significant predictors of delay. Pain severity had a nonlinear relationship with delay risk, while disease type and prior infarction history showed complex interactions.
Conclusion: Machine learning models, especially random forest, accurately predict the risk of delayed medical decision-making in AMI patients and reliably delineate the key drivers of such delay, thereby informing targeted clinical interventions.
{"title":"Development and Validation of a Machine Learning Model to Predict the Risk of Medical Decision-Making Delay in Acute Myocardial Infarction Patients From Multicenter Tertiary Hospitals in China.","authors":"Yan Liu, Fei Yu, Mingxing He, Lijun Wang, Haiyuan Wu, Wei Liu, Ping Gui, Meizhen He, Hua Zhang, Yuanting Chen","doi":"10.2147/IJGM.S562526","DOIUrl":"https://doi.org/10.2147/IJGM.S562526","url":null,"abstract":"<p><strong>Purpose: </strong>Timely reperfusion is critical for improving outcomes in patients with acute myocardial infarction (AMI), as every delay raises the incidence of complications and mortality. Therefore, we aimed to develop a machine-learning model that quantifies the risk of pre-hospital decision-making delay and visualizes how individual determinants modulate this risk.</p><p><strong>Patients and methods: </strong>This retrospective study included 594 AMI patients admitted to hospitals in Hainan from January to August 2023. Data were collected via medical systems and surveys. We used the Elastic Net and Boruta algorithms for feature selection and hyperparameter optimization with grid search and 10-fold cross-validation. Six machine learning models were developed: logistic regression, random forest, support vector machine, XGBoost, decision tree, and naive Bayes. The primary metric was the Area Under the Curve (AUC), and SHapley Additive exPlanations (SHAP) were used to assess feature importance.</p><p><strong>Results: </strong>The medical decision-making delay rate was 61.78%, with a median decision time of 3.98 hours. All models showed good predictive performance, with the random forest model excelling, achieving an AUC of 0.91, accuracy of 0.92, recall of 0.98, F1 score of 0.93, and specificity of 0.81. SHAP analysis revealed that pain severity, disease type, and history of myocardial infarction were the most significant predictors of delay. Pain severity had a nonlinear relationship with delay risk, while disease type and prior infarction history showed complex interactions.</p><p><strong>Conclusion: </strong>Machine learning models, especially random forest, accurately predict the risk of delayed medical decision-making in AMI patients and reliably delineate the key drivers of such delay, thereby informing targeted clinical interventions.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"562526"},"PeriodicalIF":2.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S559103
Runbi Ji, Ruoyu Yang, Jun Yao, Shenglan Dai, Xin Zhu, Qiang Ye
Background: The occurrence of gastric cancer is a complex pathological process leading to multiple abnormalities in clinical laboratory indicators. Machine learning techniques can make it easy to handle millions of variables to make more accurate predictions and diagnoses of diseases.
Methods: Clinical data from gastric cancer patients in a single-center who underwent surgery between 2016 and 2023 were collected. Five machine learning algorithms (extreme gradient boosting, XGBoost; random forest, RF; support vector machine-recursive feature elimination, SVM-RFE; light gradient boosting machine, LGBM; and recursive partitioning, rpart) were utilized to develop diagnostic models. Among the date, 60% were randomly selected to train the models, while the remaining 40% were used for testing. We used the area under the receiver operating characteristic curve (AUROC), F1-score value, sensitivity, and specificity to evaluate the performance of models.
Results: The XGBoost algorithm showed the best performance in gastric cancer diagnosis, with significantly higher area under curve (AUC) (combining blood indicators and pathological parameters, AUC=0.9909) value than other models. Glutathione reductase (GR), carbohydrate antigen 724 (CA724), erythrocytes (RBC), carbohydrate antigen 242 (CA242), and albumin (ALB) contributed the most to the diagnosis. The tumor size were independent risk factors for early gastric cancer.
Conclusion: Machine learning combined blood indicators and pathological parameters could predict gastric cancer risk more accurately. The XGBoost model had the best diagnostic performance. The study provides confirmatory data support for the preclinical implementation of the model.
{"title":"Machine Learning-Based Diagnostic Models for Early Gastric Cancer Using Clinical Laboratory Indicators.","authors":"Runbi Ji, Ruoyu Yang, Jun Yao, Shenglan Dai, Xin Zhu, Qiang Ye","doi":"10.2147/IJGM.S559103","DOIUrl":"https://doi.org/10.2147/IJGM.S559103","url":null,"abstract":"<p><strong>Background: </strong>The occurrence of gastric cancer is a complex pathological process leading to multiple abnormalities in clinical laboratory indicators. Machine learning techniques can make it easy to handle millions of variables to make more accurate predictions and diagnoses of diseases.</p><p><strong>Methods: </strong>Clinical data from gastric cancer patients in a single-center who underwent surgery between 2016 and 2023 were collected. Five machine learning algorithms (extreme gradient boosting, XGBoost; random forest, RF; support vector machine-recursive feature elimination, SVM-RFE; light gradient boosting machine, LGBM; and recursive partitioning, rpart) were utilized to develop diagnostic models. Among the date, 60% were randomly selected to train the models, while the remaining 40% were used for testing. We used the area under the receiver operating characteristic curve (AUROC), F1-score value, sensitivity, and specificity to evaluate the performance of models.</p><p><strong>Results: </strong>The XGBoost algorithm showed the best performance in gastric cancer diagnosis, with significantly higher area under curve (AUC) (combining blood indicators and pathological parameters, AUC=0.9909) value than other models. Glutathione reductase (GR), carbohydrate antigen 724 (CA724), erythrocytes (RBC), carbohydrate antigen 242 (CA242), and albumin (ALB) contributed the most to the diagnosis. The tumor size were independent risk factors for early gastric cancer.</p><p><strong>Conclusion: </strong>Machine learning combined blood indicators and pathological parameters could predict gastric cancer risk more accurately. The XGBoost model had the best diagnostic performance. The study provides confirmatory data support for the preclinical implementation of the model.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"559103"},"PeriodicalIF":2.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28eCollection Date: 2026-01-01DOI: 10.2147/IJGM.S553165
Bing Zhang, Fei Tian, XueJin Hu, Yong Hu, WenGang Li
Objective: This study explored the level of soluble CD13 (sCD13) and its correlation with angiogenic factors, evaluating the predictive efficacy of sCD13 in wet age-related macular degeneration (wAMD).
Methods: 200 patients were included (58 in Non AMD group, 42 in Early AMD group, and 100 in wAMD group). Detailed routine and ophthalmologic examinations were performed on all subjects, and the central retinal thickness (CRT) and ganglion cell-inner plexiform layer (GCIPL) were determined. The concentration of sCD13 was compared. The correlation of sCD13 with PDGF, hsCRP and IL-8 was analyzed. ROC curves were plotted and the diagnostic value of sCD13 was assessed by area under the curve (AUC).
Results: The sCD13 concentration of patients in the wAMD group (20.41 ± 5.86 U/mL) was higher. Age, history of smoking, CRT, hsCRP and IL-8 were higher in the wAMD group, while mean GCIPL, BCVA, and PDGF were lower. sCD13 was positively correlated with hsCRP (r = 0.505) and IL-8 (r = 0.193) and negatively correlated with PDGF (r = -0.241). sCD13 had predictive efficacy in distinguishing wAMD from non AMD and early AMD, with AUC values of 0.74 and 0.61, respectively (P < 0.05).
Conclusion: sCD13 concentration in the affected eyes of wAMD patients is abnormally elevated and associated with elevated serum hsCRP and IL-8 levels and decreased PDGF. These results suggest that elevated sCD13 may promote the development of wAMD, emphasizing the importance of early control of sCD13 levels.
{"title":"Expression Characteristics of Soluble sCD13 in Wet Age-Related Macular Degeneration and Its Diagnostic Value and Correlation Study.","authors":"Bing Zhang, Fei Tian, XueJin Hu, Yong Hu, WenGang Li","doi":"10.2147/IJGM.S553165","DOIUrl":"https://doi.org/10.2147/IJGM.S553165","url":null,"abstract":"<p><strong>Objective: </strong>This study explored the level of soluble CD13 (sCD13) and its correlation with angiogenic factors, evaluating the predictive efficacy of sCD13 in wet age-related macular degeneration (wAMD).</p><p><strong>Methods: </strong>200 patients were included (58 in Non AMD group, 42 in Early AMD group, and 100 in wAMD group). Detailed routine and ophthalmologic examinations were performed on all subjects, and the central retinal thickness (CRT) and ganglion cell-inner plexiform layer (GCIPL) were determined. The concentration of sCD13 was compared. The correlation of sCD13 with PDGF, hsCRP and IL-8 was analyzed. ROC curves were plotted and the diagnostic value of sCD13 was assessed by area under the curve (AUC).</p><p><strong>Results: </strong>The sCD13 concentration of patients in the wAMD group (20.41 ± 5.86 U/mL) was higher. Age, history of smoking, CRT, hsCRP and IL-8 were higher in the wAMD group, while mean GCIPL, BCVA, and PDGF were lower. sCD13 was positively correlated with hsCRP (r = 0.505) and IL-8 (r = 0.193) and negatively correlated with PDGF (r = -0.241). sCD13 had predictive efficacy in distinguishing wAMD from non AMD and early AMD, with AUC values of 0.74 and 0.61, respectively (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>sCD13 concentration in the affected eyes of wAMD patients is abnormally elevated and associated with elevated serum hsCRP and IL-8 levels and decreased PDGF. These results suggest that elevated sCD13 may promote the development of wAMD, emphasizing the importance of early control of sCD13 levels.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"19 ","pages":"553165"},"PeriodicalIF":2.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147511948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}